Structural models of comorbidity among common mental disorders: Connections to chronic pain

Advances in Psychosomatic Medicine

Volumn 25, Issue , 2006, Pages 63-77

  Krueger, Robert F ^a,b   Tackett, Jennifer L ^a   Markon, Kristian E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b N414 Elliott Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CHRONIC DISEASE; COMORBIDITY; DEPRESSION; HUMAN; MENTAL DISEASE; METHODOLOGY; MOOD DISORDER; PAIN; PSYCHOLOGICAL THEORY; PSYCHOTHERAPY; REVIEW;

ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; COMORBIDITY; DEPRESSION; HUMANS; MENTAL DISORDERS; MOOD DISORDERS; PAIN; PSYCHOLOGICAL THEORY; PSYCHOTHERAPY;

EID: 4544286198     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000095366     Document Type: Article

References (67)

1. Widiger TA, Sankis L: Adult psychopathology: Issues and controversies. Annu Rev Psychol 2000; 51:377-404.
2. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
3. Maser JD, Cloninger CR: Comorbidity of Mood and Anxiety Disorders. Washington, American Psychiatric Press, 1990.
4. Robins LN, Regier DA: Psychiatric Disorders in America. New York, Free Press, 1991.
5. Clark LA, Watson D, Reynolds S: Diagnosis and classification of psychopathology. Annu Rev Psychol 1995;46:121-153.
6. Widiger TA, Clark LA: Toward DSM-V and the classification of psychopathology. Psychol Bull 2000;126:946-963.
7. Kendler KS, Prescott CA, Myers J, Neale MC: The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 2003;60:929-937.
8. Krueger RF: The structure of common mental disorders. Arch Gen Psychiatry 1999;56:921-926.
9. Krueger RF, Caspi A, Moffitt TE, Silva PA: The structure and stability of common mental disorders (DSM-III-R): A longitudinal-epidemiological study. J Abnorm Psychol 1998;107: 216-227.
10. Krueger RF, Chentsova-Dutton Y, Markon K, Goldberg D, Ormel J: A cross cultural study of the structure of comorbidity among common psychopathological syndromes in the general health care setting. J Abnorm Psychol 2003;112:437-447.
11. Krueger RF, McGue M, Iacono WG: The higher-order structure of common DSM mental disorders: Internalization, externalization, and their connections to personality. Pers Indiv Diff 2001; 30:1245-1259.
12. Vollebergh WAM, Iedema J, Bijl RV, de Graff R, Smit F, Ormel J: The structure and stability of common mental disorders: The NEMESIS study. Arch Gen Psychiatry 2001;58:597-603.
13. Beck AT: Depression: Clinical, Experimental, and Theoretical Aspects. New York, Harper & Row, 1967.
14. Bradley LA, Young LD, Anderson KO, Turner RA, Agudelo CA, McDaniel LK, Pisko EJ, Semble EL, Morgan TM: Effects of psychological therapy on pain behavior of rheumatoid arthritis patients: Treatment outcome and six-month follow-up. Arthritis Rheum 1987;30:1105-1114.
15. Sharpe L, Sensky T, Timberlake N, Ryan B, Brewin CR, Allard S: A blind, randomized, controlled trial of cognitive-behavioural intervention for patients with recent onset rheumatoid arthritis: Preventing psychological and physical morbidity. Pain 2001;89:275-283.
16. Young LD: Psychological factors in rheumatoid arthritis. J Consult Clin Psychol 1992;60: 619-627.
17. Marhold C, Linton SJ, Melin L: A cognitive-behavioral return-to-work program: Effects on pain patients with a history of long-term versus short-term sick leave. Pain 2001;91:155-163.
18. Griffiths JD, Martin PR: Clinical- versus home-based treatment formats for children with chronic headache. Br J Health Psychol 1996;1:151-166.
19. Blanchard EB, Andrasik F, Evans DD, Neff DF, Appelbaum KA, Rodichok LD: Behavioral treatment of 250 chronic headache patients: A clinical replication series. Behav Ther 1985;16: 308-327.
20. Peters ML, Turner SM, Blanchard EB: The effects of aerobic exercise on chronic tension-type headache. Headache Q 1996;7:330-334.
21. Pincus T, Newman S: Recall bias, pain, depression and cost in back pain patients. Br J Clin Psychol 2001;40:143-156.
22. Turner JA, Jensen MP, Romano JM: Do beliefs, coping and catastrophizing independently predict functioning in patients with chronic pain? Pain 2000;85:115-125.
23. Hassett AL, Cone JD, Patella SJ, Sigal LH: The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 2000;43:2493-2500.
24. Haythornthwaite JA, Benrud-Larson LM: Psychological aspects of neuropathic pain. Clin J Pain 2000;16:S101-S105.
25. Hill A: The use of pain coping strategies by patients with phantom limb pain. Pain 1993;55: 347-353.
26. Roth RS, Geisser ME: Educational achievement and chronic pain disability: Mediating role of pain-related cognitions. Clin J Pain 2002;18:286-296.
27. Blanchard EB, Andrasik F: Psychological assessment and treatment of headache: Recent developments and emerging issues. J Consult Clin Psychol 1982;50:859-879.
28. Parker JC, Smarr KL, Buckelew SP, Stucky-Ropp RC, Hewett JE, Johnson JC, Wright GE, Irwin WS, Walker SE: Effects of stress management on clinical outcomes in rheumatoid arthritis. Arthritis Rheum 1995;38:1807-1818.
29. Witty TE, Heppner PP, Bernard CB, Thoreson RW: Problem-solving appraisal and psychological adjustment of persons with chronic low-back pain. J Clin Psychol Med Settings 2001;8:149-160.
30. Gibson SJ, Helme RD: Cognitive factors and the experience of pain and suffering in older persons. Pain 2000;85:375-383.
31. Jensen MP, Ehde DM, Hoffman AJ, Patterson DR, Czerniecki JM, Robinson LR: Cognitions, coping, and social environment predict adjustment to phantom limb pain. Pain 2002;95: 133-142.
32. Romano JM, Turner JA: Chronic pain and depression: Does the evidence support a relationship? Psychol Bull 1985;97:18-34.
33. Bryson HM, Wilde MI: Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging 1996;8:459-476.
34. Max MB: Antidepressant drugs as treatments for chronic pain: Efficacy and mechanisms; in Bromm B, Desmedt JE (eds): Advances in Pain Research and Therapy - Issue on Pain and the Brain: From Nociception to Cognition. New York, Raven, 1995.
35. Plesh O, Curtis D, Levine J, McCall WD: Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil 2000;27:834-841.
36. Jung AC, Staiger T, Sullivan M: The efficacy of selective serotonin reuptake inhibitors for the treatment of chronic pain. J Gen Intern Med 1997;12:384-389.
37. Onghena P, Van Houdenhove B: Antidepressant-induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo-controlled studies. Pain 1992;49:205-219.
38. Sindrup SH, Gram LF, Brosen K, Eshoy O, Morgenson EF: The selective serotonin reuptake inhibitor paraxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42: 135-144.
39. Kudoh A, Ishihara H, Matsuki A: Effect of carbamazepine on pain scores of unipolar depressed patients with chronic pain: A trial of off-on-off-on design. Clin J Pain 1998;14:61-65.
40. Newburn G, Edwards R, Thomas H, Collier J, Fox K, Collins C, Cramer D, Reeves J: A comparison of the efficacy and tolerability of moclobemide given as a single dose or in three divided doses per day for the treatment of patients with a Major Depressive Episode (DSM-III-R). J Clin Psychopharmacol 1995;15/4S:10S-15S.
41. Hudson JI, Pope HGJ: Affective spectrum disorder: Does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990;147:552-564.
42. Hudson JI, Mangweth B, Pope HGJ, De Col C, Hausmann A, Gutweniger S, Laird NM, Biebl W, Tsuang MT: Family study of affective spectrum disorder. Arch Gen Psychiatry 2003;60:170-177.
43. Wahlestedt C: Reward for persistence in substance P research. Science 1998;281:1624-1625.
44. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NMJ: Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998;281:1640-1645.
45. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS: Chronic pain-associated depression: Antecedent or consequence of chronic pain? Clin J Pain 1997;13:116-137.
46. Blier P, de Montigny C: Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994;15:220-226.
47. Potter WZ, Manji HK: Catecholamines in depression: An update. Clin Chem 1994;40:279-287.
48. Hendler N: The anatomy and psychopharmacology of chronic pain. J Clin Psychiatry 1982;43: 15-21.
49. Ward NG, Bloom VL, Dworkin S, Fawcett J, Narasimhachari N, Friedel RO: Psychobiological markers in coexisting pain and depression: Toward a unified theory. J Clin Psychiatry 1982;43: 32-39.
50. Baker GB, Greenshaw AJ: Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell Mol Neurobiol 1989;9:1-44.
51. Rupniak NM: New insights into the antidepressant actions of substance P (NK1 receptor) antagonists. Can J Physiol Pharmacol 2002;80:489-494.
52. France RD, Krishnan KR, Trainor M: Chronic pain and depression. III. Family history study of depression and alcoholism in chronic low back pain patients. Pain 1986;24:185-190.
53. Krishnan KR, France RD, Houpt JL: Chronic low back pain and depression. Psychosomatics 1985;26:299-302.
54. Reichborn-Kjennerud T, Stoltenberg C, Tambs K, Roysamb E, Kringlen E, Torgersen S, Harris JR: Back-neck pain and symptoms of anxiety and depression: A population-based twin study. Psychol Med 2002;32:1009-1020.
55. Silberg JL, Martin NG, Heath AC: Genetic and environmental factors in primary dysmenorrhea and its relationship to anxiety, depression, and neuroticism. Behav Genet 1987;17:363-383.
56. Treloar SA, Heath AC, Martin NG: Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychol Med 2002;32:25-38.
57. Ribeiro-da-Silva A, Hokfelt T: Neuroanatomical localisation of substance P in the CNS and sensory neurons. Neuropeptides 2000;34:256-271.
58. Santarelli L, Gobbi G, Debs PC, Sibille EL, Blier P, Hen R, Heath MJS: Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 2001;98:1912-1917.
59. Zimmer A, Zimmer AM, Baffi J, Usdin T, Reynolds K, Konig M, Palkovits M, Mezey E: Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci USA 1998;95:2630-2635.
60. Bilkei-Gorzo A, Racz I, Michel K, Zimmer A: Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. J Neurosci 2002;22:10046-10052.
61. Froger N, Gardier AM, Moratalla R, Alberti I, Lena I, Boni C, De Felipe C, Rupniak NMJ, Hunt SP, Jacquot C, Hamon M, Lanfumey L: 5-Hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J Neurosci 2001;21:8188-8197.
62. Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A: Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 1996;383: 535-538.
63. Koster A, Montkowski A, Schulz S, Stube EM, Knaudt K, Jenck F, Moreau JL, Nothacker HP, Civelli O, Reinscheid RK: Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA 1999;96: 10444-10449.
64. Ustun TB, Sartorius N: Mental Illness in General Health Care: An International Study. New York, Wiley, 1995.
65. Tyrer P: Neurosis divisible? Lancet 1985;i:685-688.
66. Andrews G, Stewart G, Morris-Yates A, Hold P, Henderson S: Evidence for a general neurotic syndrome. Br J Psychiatry 1990;157:6-12.
67. Krueger RF, Piasecki TM: Toward a dimensional and psychometrically-informed approach to conceptualizing psychopathology. Behav Res Ther 2002;40:485-499.